Jordi Camarasa
Overview
    Explore the profile of Jordi Camarasa including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              22
            
            
              Citations
              193
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Urquizu E, Paratusic S, Goyenechea J, Gomez-Canela C, Fumas B, Pubill D, et al.
  
  
    Int J Mol Sci
    . 2024 Nov;
          25(22).
    
    PMID: 39596313
  
  
          The secondary neurotoxicity induced by severe organophosphorus (OP) poisoning, including paraoxon (POX), is associated with cognitive impairments in survivors, who, despite receiving appropriate emergency treatments, may still experience lasting neurological...
      
2.
        
    
    Puigseslloses P, Nadal-Gratacos N, Ketsela G, Weiss N, Berzosa X, Estrada-Tejedor R, et al.
  
  
    Mol Psychiatry
    . 2024 Mar;
          29(8):2346-2358.
    
    PMID: 38486047
  
  
          Recent studies have sparked renewed interest in the therapeutic potential of psychedelics for treating depression and other mental health conditions. Simultaneously, the novel psychoactive substances (NPS) phenomenon, with a huge...
      
3.
        
    
    Lopez-Arnau R, Camarasa J, Carbo M, Nadal-Gratacos N, Puigseslloses P, Espinosa-Velasco M, et al.
  
  
    Front Psychiatry
    . 2022 Oct;
          13:990405.
    
    PMID: 36262632
  
  
          The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive...
      
4.
        
    
    Espinosa-Velasco M, Reguilon M, Bellot M, Nadal-Gratacos N, Berzosa X, Gomez-Canela C, et al.
  
  
    Prog Neuropsychopharmacol Biol Psychiatry
    . 2022 May;
          117:110562.
    
    PMID: 35500841
  
  
          N-ethyl-pentedrone (NEPD, 2-(ethylamino)-1-phenyl-1-pentanone) is one of the latest synthetic cathinone derivatives that emerged into the illicit drug market. This drug has psychostimulant properties and has been related with several intoxications...
      
5.
        
    
    Nadal-Gratacos N, Lleixa E, Gibert-Serramia M, Estrada-Tejedor R, Berzosa X, Batllori X, et al.
  
  
    Int J Mol Sci
    . 2022 Feb;
          23(4).
    
    PMID: 35216339
  
  
          Changes in the molecular structure of synthetic cathinones has led to an increase in the number of novel emerging drugs in the illicit drug market at an unprecedented rate. Unfortunately,...
      
6.
        
    
    Espinosa-Velasco M, Reguilon M, Bellot M, Nadal-Gratacos N, Berzosa X, Puigseslloses P, et al.
  
  
    J Neurochem
    . 2021 Nov;
          160(2):218-233.
    
    PMID: 34816436
  
  
          N-ethyl-pentylone (NEP), also known as 'ephylone' and N-ethylnorpentylone, has been identified as one of the most recent novel psychostimulants to emerge into the illicit drug market and it has been...
      
7.
        
    
    Nadal-Gratacos N, Alberto-Silva A, Rodriguez-Soler M, Urquizu E, Espinosa-Velasco M, Jantsch K, et al.
  
  
    Front Pharmacol
    . 2021 Nov;
          12:749429.
    
    PMID: 34764870
  
  
          Several new synthetic cathinones, which mimic the effect of classical psychostimulants such as cocaine or MDMA, have appeared in the global illicit drug market in the last decades. In fact,...
      
8.
        
    
    Alegre-Zurano L, Lopez-Arnau R, Lujan M, Camarasa J, Valverde O
  
  
    Int J Mol Sci
    . 2021 Aug;
          22(15).
    
    PMID: 34361071
  
  
          3,4-Methylenedioxypyrovalerone (MDPV) is a new psychoactive substance (NPS) and the most widespread and life-threatening synthetic cathinone of the "bath salts". Preclinical research has proven the cocaine-like psychostimulant effects of MDPV...
      
9.
        
    
    Abad S, Ramon-Duaso C, Lopez-Arnau R, Folch J, Pubill D, Camarasa J, et al.
  
  
    J Psychopharmacol
    . 2019 Jun;
          33(9):1170-1182.
    
    PMID: 31219369
  
  
          Background: 3,4-Methylenedioxymethamphetamine (MDMA) is still one of the most consumed drugs by adolescents. Its abuse is related with cognitive impairment, which seems due to maladaptive plasticity and neural stress. In...
      
10.
        
    
    Camarasa J, Rodrigo T, Pubill D, Escubedo E
  
  
    Biomol Concepts
    . 2014 Dec;
          3(1):1-12.
    
    PMID: 25436520
  
  
          Abstract The 20th century brought with it the so-called club drugs (the most notorious being amphetamine derivatives), which are used by young adults at all-night dance parties. Methamphet-amine and 3,4-methylenedioxymethamphetamine...